BNP Paribas Asset Management’s PTC Therapeutics PTCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$38.6M Buy
789,494
+160,836
+26% +$7.86M 0.09% 216
2025
Q1
$32M Buy
628,658
+44,332
+8% +$2.26M 0.09% 236
2024
Q4
$26.4M Buy
584,326
+112,038
+24% +$5.06M 0.07% 283
2024
Q3
$17.5M Buy
472,288
+26,773
+6% +$993K 0.04% 330
2024
Q2
$13.6M Buy
445,515
+6,150
+1% +$188K 0.04% 366
2024
Q1
$12.8M Buy
439,365
+35,173
+9% +$1.02M 0.03% 391
2023
Q4
$11.1M Sell
404,192
-155,133
-28% -$4.28M 0.03% 404
2023
Q3
$12.5M Buy
559,325
+31,379
+6% +$703K 0.04% 352
2023
Q2
$21.5M Sell
527,946
-77,174
-13% -$3.14M 0.07% 281
2023
Q1
$29.3M Sell
605,120
-25,230
-4% -$1.22M 0.1% 218
2022
Q4
$24.1M Buy
630,350
+212,515
+51% +$8.11M 0.09% 264
2022
Q3
$21M Buy
417,835
+107,993
+35% +$5.42M 0.08% 276
2022
Q2
$12.4M Buy
309,842
+114,323
+58% +$4.58M 0.05% 372
2022
Q1
$7.3M Sell
195,519
-22,559
-10% -$842K 0.03% 470
2021
Q4
$8.69M Buy
218,078
+43,899
+25% +$1.75M 0.03% 473
2021
Q3
$6.48M Sell
174,179
-93,898
-35% -$3.49M 0.02% 490
2021
Q2
$11.3M Sell
268,077
-58,230
-18% -$2.46M 0.04% 412
2021
Q1
$15.5M Sell
326,307
-118,119
-27% -$5.59M 0.06% 334
2020
Q4
$27.1M Sell
444,426
-4,209
-0.9% -$257K 0.13% 197
2020
Q3
$21M Buy
448,635
+58,425
+15% +$2.73M 0.12% 212
2020
Q2
$19.8M Buy
390,210
+4,774
+1% +$242K 0.13% 187
2020
Q1
$17.2M Sell
385,436
-20,521
-5% -$915K 0.15% 189
2019
Q4
$19.5M Buy
405,957
+77,569
+24% +$3.73M 0.13% 208
2019
Q3
$11.1M Sell
328,388
-61,949
-16% -$2.1M 0.09% 281
2019
Q2
$17.6M Buy
390,337
+24,663
+7% +$1.11M 0.14% 196
2019
Q1
$13.8M Buy
365,674
+121,257
+50% +$4.56M 0.12% 233
2018
Q4
$7.82M Buy
244,417
+11,233
+5% +$360K 0.07% 327
2018
Q3
$11M Buy
+233,184
New +$11M 0.08% 318
2015
Q2
Sell
-5,160
Closed -$314K 1068
2015
Q1
$314K Sell
5,160
-892
-15% -$54.3K ﹤0.01% 974
2014
Q4
$313K Buy
+6,052
New +$313K ﹤0.01% 894